SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-23-011442
Filing Date
2023-03-31
Accepted
2023-03-31 17:26:21
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A ktra_defa_14a_2023.htm DEFA14A 34400
2 GRAPHIC img246083388_0.jpg GRAPHIC 69394
3 GRAPHIC img246083388_1.jpg GRAPHIC 84290
  Complete submission text file 0000950170-23-011442.txt   247495
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121 (858) 350-4364
Kintara Therapeutics, Inc. (Filer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: DEFA14A | Act: 34 | File No.: 001-37823 | Film No.: 23789324
SIC: 2834 Pharmaceutical Preparations